Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q1 2026 · 10-Q
Revenue$76.04M$76.04M−34.3% vs Q1 2025 Net Income-$2.12M-$2.12MN/M vs Q1 2025 EPS Diluted-$0.19-$0.19N/M vs Q1 2025 Gross Profit$51,756,000−38.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flow$260,000−92.4% Free Cash Flowderived-$836,000N/M Margins · derivedGross margin68.1%−4.7 pt vs Q1 2025
Operating margin-4.3%−3.2 pt vs Q1 2025
Net margin-2.8%−2.1 pt vs Q1 2025
ended Mar 31, 2026 · filed May 4, 2026 · 34 d after period end